Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on October 7, 2002

Circulation. 2002
Published online before print October 7, 2002, doi: 10.1161/01.CIR.0000033970.22130.93
A more recent version of this article appeared on October 29, 2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
106/18/2385    most recent
01.CIR.0000033970.22130.93v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zobel, C.
Right arrow Articles by Backx, P. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zobel, C.
Right arrow Articles by Backx, P. H.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
*PHENYLEPHRINE
Related Collections
Right arrow Hypertrophy
Right arrow Gene therapy
Right arrow Calcium cycling/excitation-contraction coupling
Right arrow Cell signalling/signal transduction
Right arrow Ion channels/membrane transport
Right arrow Physiological and pathological control of gene expression

Submitted on March 28, 2002
Revised on July 31, 2002
Accepted on August 2, 2002

Prevention of Hypertrophy by Overexpression of Kv4.2 in Cultured Neonatal Cardiomyocytes

Carsten Zobel MD, Zameneh Kassiri PhD, The-Tin T. Nguyen MsC, Yang Meng PhD, and Peter H. Backx DVM, PhD*

From the Departments of Physiology and Medicine, Division of Cardiology University Health Network and Heart & Stroke Richard Lewar Centre, University of Toronto, Ontario, Canada. Dr Zobel is now at the Laboratory of Muscle Research and Molecular Cardiology, Clinic III for Internal Medicine, University of Cologne, Joseph-Stelzmann-str. 9, 50924 Cologne, Germany.

* To whom correspondence should be addressed. E-mail: p.backx{at}utoronto.ca.

Background—Prolonged action potentials (APs) and decreased transient outward K+ currents (Ito) are consistent findings in hypertrophic myocardium. However, the connection of these changes with cardiac hypertrophy is unknown. The present study investigated the effects of changes in Ito and the associated alterations in AP on myocyte hypertrophy induced by phenylephrine.

Methods and Results—Chronic incubation of cultured neonatal ventricular rat myocytes (NVRMs) with phenylephrine (PE) reduced Ito density and prolonged AP duration, leading to a 2-fold increase in the net Ca2+ influx per beat and a 1.4-fold increase in Ca2+-transient amplitude. PE treatment of chronically paced (2-Hz) NVRM also induced increases in cell size, protein/DNA ratio, atrial natriuretic factor mRNA expression, as well as ß/{alpha} myosin mRNA ratio. These hypertrophic changes were associated with a 2.4-fold increase in activation of nuclear factor of activated T-cells (NFAT), indicating increased activity of the Ca2+-dependent phosphatase calcineurin. Overexpression of Kv4.2 channels using adenovirus prevented the AP duration prolongation as well as the increases in Ca2+ influx and Ca2+-transient amplitude induced by PE. Kv4.2 overexpression also prohibited the PE-induced increases in cell size, protein/DNA ratio, atrial natriuretic factor expression, ß/{alpha} myosin mRNA ratio, and NFAT activation.

Conclusions—Our results demonstrate that PE-mediated hypertrophy in NRVMs seems to require Ito reductions and AP prolongation associated with increased Ca2+ influx and Ca2+ transients as well as calcineurin activation. The clinical implications of these studies and the possible involvement of other signaling pathways are discussed.


Key words: action potentials • myocytes • ion channels • hypertrophy • calcium




This article has been cited by other articles:


Home page
Sci SignalHome page
S. R. Houser and J. D. Molkentin
Does Contractile Ca2+ Control Calcineurin-NFAT Signaling and Pathological Hypertrophy in Cardiac Myocytes?
Sci. Signal., June 24, 2008; 1(25): pe31 - pe31.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K.-H. Kim, G. Y. Oudit, and P. H. Backx
Erythropoietin Protects against Doxorubicin-Induced Cardiomyopathy via a Phosphatidylinositol 3-Kinase-Dependent Pathway
J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 160 - 169.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. Saygili, O. R. Rana, E. Saygili, H. Reuter, K. Frank, R. H. G. Schwinger, J. Muller-Ehmsen, and C. Zobel
Losartan prevents stretch-induced electrical remodeling in cultured atrial neonatal myocytes
Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2898 - H2905.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. Sun, B.-G. Kerfant, D. Zhao, M. G. Trivieri, G. Y. Oudit, J. M. Penninger, and P. H. Backx
Insulin-Like Growth Factor-1 and PTEN Deletion Enhance Cardiac L-Type Ca2+ Currents via Increased PI3K{alpha}/PKB Signaling
Circ. Res., June 9, 2006; 98(11): 1390 - 1397.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Xu, N. L. Gong, I. Bodi, B. J. Aronow, P. H. Backx, and J. D. Molkentin
Myocyte Enhancer Factors 2A and 2C Induce Dilated Cardiomyopathy in Transgenic Mice
J. Biol. Chem., April 7, 2006; 281(14): 9152 - 9162.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Y. Jia and K. Takimoto
Mitogen-Activated Protein Kinases Control Cardiac KChIP2 Gene Expression
Circ. Res., February 17, 2006; 98(3): 386 - 393.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
W. Guo, W. E. Jung, C. Marionneau, F. Aimond, H. Xu, K. A. Yamada, T. L. Schwarz, S. Demolombe, and J. M. Nerbonne
Targeted Deletion of Kv4.2 Eliminates Ito,f and Results in Electrical and Molecular Remodeling, With No Evidence of Ventricular Hypertrophy or Myocardial Dysfunction
Circ. Res., December 9, 2005; 97(12): 1342 - 1350.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
T. Volk, P. J. Noble, M. Wagner, D. Noble, and H. Ehmke
Ascending aortic stenosis selectively increases action potential-induced Ca2+ influx in epicardial myocytes of the rat left ventricle
Exp Physiol, January 1, 2005; 90(1): 111 - 121.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Perrier, R. Perrier, S. Richard, and J.-P. Benitah
Ca2+ Controls Functional Expression of the Cardiac K+ Transient Outward Current via the Calcineurin Pathway
J. Biol. Chem., September 24, 2004; 279(39): 40634 - 40639.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y. Wakisaka, S. Niwano, H. Niwano, J. Saito, T. Yoshida, S. Hirasawa, H. Kawada, and T. Izumi
Structural and electrical ventricular remodeling in rat acute myocarditis and subsequent heart failure
Cardiovasc Res, September 1, 2004; 63(4): 689 - 699.
[Abstract] [Full Text] [PDF]